Johnson & Johnson inventory jumps towards 2-month excessive after revenue, gross sales beat…
Shares of Johnson & Johnson
JNJ,
+1.30%
rose 2.3% towards a two-month excessive in premarket buying and selling Tuesday, after the drug and client merchandise firm reported third-quarter revenue…